Graham Craggs

797 total citations
8 papers, 650 citations indexed

About

Graham Craggs is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Graham Craggs has authored 8 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Graham Craggs's work include Mast cells and histamine (2 papers), Ubiquitin and proteasome pathways (2 papers) and Protein Tyrosine Phosphatases (2 papers). Graham Craggs is often cited by papers focused on Mast cells and histamine (2 papers), Ubiquitin and proteasome pathways (2 papers) and Protein Tyrosine Phosphatases (2 papers). Graham Craggs collaborates with scholars based in United Kingdom, Japan and Australia. Graham Craggs's co-authors include Fred Sablitzky, John D. Norton, Richard W. Deed, Stuart Kellie, Gareth E. Jones, Ian N. Bird, Jackie de Belin, Athula Herath, Michael J. O’Hare and Francesco Pezzella and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Cell Science and Trends in Cell Biology.

In The Last Decade

Graham Craggs

8 papers receiving 639 citations

Peers

Graham Craggs

MB

IMMUN

ONCOL

CR

GENET

Rong-Hua Tao United States

Matthew Adlam United States

Fiona McLaughlin United Kingdom

Jaime Symowicz United States

Paul Bushway United States

Carole Voland France

Chaoting Liu United States

Junfeng Wu China

Allen Saliganan United States

Roger S. Jackson United States

Rong-Hua Tao United States

Graham Craggs

430 ×0.9

MB

115 ×0.9

IMMUN

152 ×1.2

ONCOL

47 ×0.4

CR

41 ×0.8

GENET

Citations per year, relative to Graham Craggs Graham Craggs (= 1×) peers Rong-Hua Tao

Countries citing papers authored by Graham Craggs

Since Specialization

Citations

This map shows the geographic impact of Graham Craggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Craggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Craggs more than expected).

Fields of papers citing papers by Graham Craggs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Craggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Craggs. The network helps show where Graham Craggs may publish in the future.

Co-authorship network of co-authors of Graham Craggs

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Craggs. A scholar is included among the top collaborators of Graham Craggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Craggs. Graham Craggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Qureshi, Omar, Shauna West, Graham Craggs, et al.. (2024). Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro. mAbs. 16(1). 2300155–2300155. 3 indexed citations

2.

Davies, Anna M., Anthony H. Keeble, Benjamin P. Cossins, et al.. (2017). Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab. Journal of Biological Chemistry. 292(24). 9975–9987. 62 indexed citations

3.

Kellie, Stuart, Graham Craggs, Ian N. Bird, & Gareth E. Jones. (2004). The tyrosine phosphatase DEP-1 induces cytoskeletal rearrangements, aberrant cell-substratum interactions and a reduction in cell proliferation. Journal of Cell Science. 117(4). 609–618. 34 indexed citations

4.

Adam, Paul J., Joanne Berry, Julie Loader, et al.. (2003). Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.. PubMed. 1(11). 826–35. 89 indexed citations

5.

Craggs, Graham & Stuart Kellie. (2001). A Functional Nuclear Localization Sequence in the C-terminal Domain of SHP-1. Journal of Biological Chemistry. 276(26). 23719–23725. 56 indexed citations

6.

Craggs, Graham, Peter M. Finan, Durward Lawson, et al.. (2001). A Nuclear SH3 Domain-binding Protein That Colocalizes with mRNA Splicing Factors and Intermediate Filament-containing Perinuclear Networks. Journal of Biological Chemistry. 276(32). 30552–30560. 21 indexed citations

7.

Murray, James T., Graham Craggs, Laura C. Wilson, & Stuart Kellie. (2000). Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: Phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis. Inflammation Research. 49(11). 610–618. 14 indexed citations

8.

Norton, John D., Richard W. Deed, Graham Craggs, & Fred Sablitzky. (1998). Id helix—loop—helix proteins in cell growth and differentiation. Trends in Cell Biology. 8(2). 58–65. 371 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact